Cel-Sci
CVM
#9834
Rank
S$49.6 M
Marketcap
S$5.90
Share price
2.19%
Change (1 day)
-56.76%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of September 2025 : S$11.87 Million

According to Cel-Sci 's latest financial reports the company's total debt is S$11.87 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-09-30S$12.1 M-18.93%
2024-09-30S$14.93 M-19.45%
2023-09-30S$18.54 M-15.6%
2022-09-30S$21.96 M1.25%
2021-09-30S$21.69 M14.06%
2020-09-30S$19.02 M1.87%
2019-09-30S$18.67 M2.06%
2018-09-30S$18.29 M-5.25%
2017-09-30S$19.3 M8.77%
2016-09-30S$17.75 M-10.21%
2015-09-30S$19.76 M1281.41%
2014-09-30S$1.43 M0.61%
2013-09-30S$1.42 M4.83%
2012-09-30S$1.35 M-79.1%
2011-09-30S$6.49 M347.1%
2010-09-30S$1.45 M-7.35%
2009-09-30S$1.56 M445.42%
2008-09-30S$0.28 M
2005-09-30S$0 M0.56%
2004-09-30S$0 M-99.67%
2003-09-30S$1.5 M-52.14%
2002-09-30S$3.15 M5623.36%
2001-09-30S$0.05 M27.61%
2000-09-30S$0.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$60.67 B 510,700.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$69.09 B 581,609.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$87.68 M 638.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S$2.49 M-79.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$21.63 B 182,063.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
S$0.81 B 6,777.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.83 B 6,966.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$0.69 M-94.12%๐Ÿ‡บ๐Ÿ‡ธ USA